iCare RETCAD is an AI-powered software solution designed to analyze color fundus images for the early detection of vision-threatening conditions such as diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucoma. This solution leverages advanced deep learning and computer vision technologies to provide accurate and reliable analysis results.
iCare RETCAD transforms retinal disease detection by harnessing AI-driven image analysis to support healthcare professionals in identifying vision-threatening conditions. It delivers accurate, reliable results that enhance clinical decision-making.
When combined with iCare DRSplus and iCare ILLUME, iCare RETCAD creates a comprehensive screening solution. By integrating detail-rich confocal fundus imaging and cutting-edge AI-powered retinal image analysis, the iCare screening solution streamlines workflows, enhances diagnostic accuracy, and improves the patient care journey.
Retinal diseases account for up to 80% of preventable blindness cases, with global vision loss costs approaching $3 trillion annually. Early detection is critical. iCare RETCAD’s AI-driven analysis transforms retinal image interpretation by delivering intuitive reports that help healthcare professionals make informed decisions quickly and accurately, improving patient outcomes and engagement.
• Quick image capture: Digital color fundus cameras acquire images in seconds.
• Automated analysis: AI processes images, generating scores and heat maps.
• GDPR compliance: Patient data is pseudonymized for secure handling.
• Fast results: Analysis takes approximately one minute.
• Accessible reports: Results integrate directly into existing software.
iCare RETCAD is compatible with all major fundus camera vendors, ensuring versatility in diverse clinical and optical settings. While its adaptability extends to various imaging devices, its most transformative capabilities shine when used with iCare DRSplus and iCare ILLUME. Together, they redefine the possibilities of remote retinal screening, offering consistent performance and better patient care.
With iCare RETCAD, eye care specialists gain an advanced tool for safeguarding vision, streamlining workflows, and enhancing the patient care journey—while the final diagnosis remains in the hands of the doctor.
With artificial intelligence, healthcare organizations can conduct large-scale eye screenings efficiently and accurately. iCare RETCAD delivers results that match—or even surpass—traditional vision screening methods in reliability. By instantly analyzing every patient’s retinal image using clinically validated software trained to detect disease patterns, iCare RETCAD empowers fast, precise, and scalable screening for entire populations.
Using artificial intelligence, opticians can now detect early signs of age-related macular degeneration, diabetic retinopathy and glaucoma, enabling faster diagnosis. iCare RETCAD, combined with fundus imaging, delivers reliable and consistent performance regardless of workload or time of day. With AI-powered precision, disease detection takes only a few minutes, providing validated, actionable results instantly.
iCare RETCAD seamlessly integrates into clinic-specific workflows, reducing workloads for certified eye care specialists and enhancing clinical capacity. By enabling faster and objective prioritization of patients requiring immediate follow-up, iCare RETCAD transforms eye care. Ophthalmologists can now identify severe symptoms more efficiently, helping more patients receive timely, life-changing care.
Local qualified iCare distributors are ready to help you with all matters related to iCare products and services.
Contact usGet support materials for your iCare products by filling in the form.
Material request
